250 related articles for article (PubMed ID: 16022084)
21. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
Napolitano LM
Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
[TBL] [Abstract][Full Text] [Related]
22. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
Lamb HM; Figgitt DP; Faulds D
Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
[TBL] [Abstract][Full Text] [Related]
23. New treatment options and protocols for peritoneal dialysis-related peritonitis.
Furgeson SB; Teitelbaum I
Contrib Nephrol; 2009; 163():169-176. PubMed ID: 19494611
[TBL] [Abstract][Full Text] [Related]
24. New antimicrobial agents as therapy for resistant gram-positive cocci.
Lentino JR; Narita M; Yu VL
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):3-15. PubMed ID: 17899228
[TBL] [Abstract][Full Text] [Related]
25. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
Loza E; Morosini MI; Pascual A; Tubau F; Alcalá J; Liñares J; Hernández-Bello JR; Baquero F; Perea E; Martín R; Jones RN; Cantón R;
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
[TBL] [Abstract][Full Text] [Related]
26. Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists.
Akins RL; Haase KK
Pharmacotherapy; 2005 Jul; 25(7):1001-10. PubMed ID: 16006278
[TBL] [Abstract][Full Text] [Related]
27. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci.
Rivera AM; Boucher HW
Mayo Clin Proc; 2011 Dec; 86(12):1230-43. PubMed ID: 22134942
[TBL] [Abstract][Full Text] [Related]
28. Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.
Huen SC; Hall I; Topal J; Mahnensmith RL; Brewster UC; Abu-Alfa AK
Am J Kidney Dis; 2009 Sep; 54(3):538-41. PubMed ID: 19237231
[TBL] [Abstract][Full Text] [Related]
29. Optimizing antimicrobial therapy for gram-positive bloodstream infections in patients on hemodialysis.
Pai AB; Pai MP
Adv Chronic Kidney Dis; 2006 Jul; 13(3):259-70. PubMed ID: 16815231
[TBL] [Abstract][Full Text] [Related]
30. Peritonitis in recent years: clinical findings and predictors of treatment response of 170 episodes at a single Brazilian center.
Oliveira LG; Luengo J; Caramori JC; Montelli AC; Cunha Mde L; Barretti P
Int Urol Nephrol; 2012 Oct; 44(5):1529-37. PubMed ID: 22302733
[TBL] [Abstract][Full Text] [Related]
31. [Clinical features and antimicrobial resistance of Gram positive bacterial blood stream infection in patients with hematologic diseases].
Cao WB; Su D; Chen YM; Zheng YZ; Zhang FK; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):566-9. PubMed ID: 22967420
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial agents for treatment of serious infections caused by resistant Staphylococcus aureus and enterococci.
Eliopoulos GM
Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):826-31. PubMed ID: 16315008
[TBL] [Abstract][Full Text] [Related]
33. Quinupristin-dalfopristin.
Bryson HM; Spencer CM
Drugs; 1996 Sep; 52(3):406-15. PubMed ID: 8875130
[TBL] [Abstract][Full Text] [Related]
34. Vancomycin and ciprofloxacin: systemic antibiotic administration for peritoneal dialysis-associated peritonitis.
Goffin E; Herbiet L; Pouthier D; Pochet JM; Lafontaine JJ; Christophe JL; Gigi J; Vandercam B
Perit Dial Int; 2004; 24(5):433-9. PubMed ID: 15490982
[TBL] [Abstract][Full Text] [Related]
35. Clinical course and outcomes of single-organism Enterococcus peritonitis in peritoneal dialysis patients.
Yip T; Tse KC; Ng F; Hung I; Lam MF; Tang S; Lui SL; Lai KN; Chan TM; Lo WK
Perit Dial Int; 2011; 31(5):522-8. PubMed ID: 21532006
[TBL] [Abstract][Full Text] [Related]
36. Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.
Ma TK; Leung CB; Chow KM; Kwan BC; Li PK; Szeto CC
Clin Kidney J; 2016 Aug; 9(4):616-23. PubMed ID: 27478608
[TBL] [Abstract][Full Text] [Related]
37. Use of cefazolin for peritonitis treatment in peritoneal dialysis patients.
Agraharkar M; Klevjer-Anderson P; Rubinstien E; Galen M
Am J Nephrol; 1999; 19(5):555-8. PubMed ID: 10575183
[TBL] [Abstract][Full Text] [Related]
38. National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia.
Shibl AM; Memish ZA; Kambal AM; Ohaly YA; Ishaq A; Senok AC; Livermore DM
J Chemother; 2014 Feb; 26(1):13-8. PubMed ID: 24091308
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal dialysis fluid concentrations of linezolid in the treatment of vancomycin-resistant Enterococcus faecium peritonitis.
DePestel DD; Peloquin CA; Carver PL
Pharmacotherapy; 2003 Oct; 23(10):1322-6. PubMed ID: 14594349
[TBL] [Abstract][Full Text] [Related]
40. Novel antibacterial agents for the treatment of serious Gram-positive infections.
Abbanat D; Macielag M; Bush K
Expert Opin Investig Drugs; 2003 Mar; 12(3):379-99. PubMed ID: 12605562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
